The U.S. cannabis market size is anticipated to reach USD 76.39 billion by 2030 and is projected to grow at a CAGR of 12.10% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as legalization of medicinal cannabis, growing consumer disposable income, rising demand for cannabis from the pharmaceutical industry, growing consumer awareness of the health benefits of cannabis, presence of major manufacturers, and the approval of the U.S. farm bill are expected to boost the market growth.
Cannabis is generally used for the treatment of various conditions, such as cancer, mental disorders, pain management, & nausea, and for recreational purposes. The high prevalence of cancer is expected to be one of the factors driving the adoption of medical marijuana over the forecast period. For instance, according to an article published by the American Cancer Society in January 2023, 609,820 cancer deaths and 1,958,310 new cancer cases were anticipated to occur in the U.S. In addition to that, two cannabidiol (CBD) drugs namely nabilone and dronabinol are approved by the FDA for the treatment of vomiting and nausea caused by chemotherapy in the U.S.
Rising awareness among people regarding the therapeutic benefits of cannabis and the launch of cannabis certification programs through partnerships drives market growth. For instance, in December 2023, Bellarmine University introduced a cannabis education certificate program offered by a public Kentucky University focusing on agriculture, business, medicine, and law in the fast-changing cannabis industry.
With the legalization of cannabis in different areas of the U.S. for medical & recreational use, many well-known personalities and mainstream companies are seeking to benefit from this trend. For instance, celebrities such as Jay-Z and Snoop Dogg have joined this movement by launching branded cannabis products (Monogram). However, avid cannabis consumers seek information regarding the extent of the celebrity’s involvement in the cultivation process. Despite this scrutiny, more celebrities are expected to follow this trend and enter the cannabis cultivation industry.
New technologies and improvements are continually being developed for the cultivation of cannabis. With an increasing demand for technologically advanced cannabis production, these expanded techniques are anticipated to assist cultivators in optimizing their resources, which further drives the market growth.
Request a free sample copy or view report summary: U.S. Cannabis Market Report
Based on source, the marijuana segment led the market with the largest revenue share of 86.91% in 2023, due to the recognition of cannabis for medical purposes and the increasing legalization of its use
Based on derivative, the CBD segment led the market with the largest revenue share of 64.7% in 2023, owing to growing acceptance and a rise in demand for CBD-infused food, cosmetics, and medication
Based on cultivation, the indoor cultivation segment led the market with the largest revenue share of 54.59% in 2023, owing to favorable government initiatives and investment made by key players in the market
Based on end use, the medical use segment led the market with the largest revenue share of 66.41% in 2023 due to the increasing research activity and growing clinical trials supporting its benefits in treating various chronic disease.
Grand View Research, Inc. has segmented the U.S. cannabis market report based on source, derivatives, end-use, and cultivation:
U.S. Cannabis Source Outlook (Revenue, USD Million, 2018 - 2030)
Hemp
Hemp Oil
Industrial Hemp
Marijuana
Flower
Oil & Tinctures
U.S. Cannabis Derivative Outlook (Revenue, USD Million, 2018 - 2030)
CBD
THC
Others
U.S. Cannabis Cultivation Outlook (Revenue, USD Million, 2018 - 2030)
Indoor Cultivation
Greenhouse Cultivation
Outdoor Cultivation
U.S. Cannabis End-use Type Outlook (Revenue, USD Million, 2018 - 2030)
Industrial Use
Medical Use
Chronic Pain
Depression & Anxiety
Arthritis
Post Traumatic Stress Disorder (PTSD)
Cancer
Migraines
Epilepsy
Alzheimer’s Disease
Multiple Sclerosis
AIDS
Amyotrophic Lateral Sclerosis
Tourette’s Syndrome
Diabetes
Parkinson's Disease
Glaucoma
Others
Recreational Use
List of Key Players in U.S. Cannabis Market
Medical Marijuana, Inc.
NuLeaf Naturals, LLC
CV Sciences, Inc.
CHARLOTTE’S WEB.
The Cronos Group
Organigram Holding, Inc.
Irwin Naturals
Tilray Brands
Canopy Growth Corporation
Aurora Cannabis
"The quality of research they have done for us has been excellent..."